coronavirus
infect
human
caus
mild
diseas
wherea
sever
acut
respiratori
syndrom
sar
associ
coronaviru
extrem
danger
pathogen
report
develop
serolog
assay
detect
antibodi
human
coronavirus
hcov
base
recombin
nucleocapsid
n
protein
known
pathogen
strain
sar
novel
immunoassay
highli
use
epidemiolog
survey
use
nucleic
acid
diagnost
often
limit
purifi
recombin
antigen
immobil
nitrocellulos
membran
appli
line
immunoassay
allow
rapid
detect
antibodi
differ
hcov
singl
experi
assay
evalu
serum
sampl
person
infect
acuteconvalesc
recov
sar
patient
healthi
donor
analyz
screen
nucleocapsid
n
specif
immunoglobulin
g
igg
convalesc
sera
reach
sensit
new
techniqu
found
recent
identifi
contribut
significantli
overal
spectrum
coronaviru
infect
possibl
crossreact
antibodi
respons
observ
use
serum
pair
howev
potenti
assay
could
clearli
demonstr
employ
sarsposit
serum
sampl
nonspecif
bind
nucleocapsid
hcov
observ
coronaviru
strainspecif
line
immunoassay
repres
power
tool
serolog
diagnost
coronavirus
famili
coronavirida
order
nidoviral
larg
nm
envelop
roughli
spheric
particl
possess
nonseg
singlestrand
rna
genom
kb
posit
orient
base
serolog
crossreact
sequenc
analysi
coronavirus
classifi
distinct
group
gorbalenya
et
al
kim
et
al
weiss
navasmartin
coronavirus
known
infect
mani
domest
anim
well
human
caus
acut
chronic
diseas
respiratori
enter
central
nervou
system
weiss
navasmartin
human
coronavirus
hcov
describ
hamr
et
al
mcintosh
et
al
thought
respons
common
cold
larson
et
al
myint
new
infecti
diseas
sever
acut
respiratori
syndrom
sar
emerg
novemb
guangdong
provinc
peopl
republ
china
within
month
sar
spread
countri
infect
peopl
almost
die
poutanen
low
etiolog
agent
recogn
novel
viru
term
sarscov
drosten
et
al
relat
distinct
known
coronavirus
recent
find
suggest
close
relationship
sarscov
group
ii
coronavirus
kim
et
al
van
der
hoek
et
al
report
isol
new
group
cov
child
bronchiol
name
independ
describ
virus
hcovnl
fouchier
et
al
hcovnh
esper
et
al
close
relat
like
repres
strain
speci
viru
kahn
link
sever
ailment
morbu
croup
system
vascul
young
children
kawasaki
diseas
although
associ
latter
discuss
controversi
esper
et
al
shimizu
et
al
infect
report
throughout
world
arden
et
al
bastien
et
al
chiu
et
al
garbino
et
al
indic
hcov
regard
new
major
etiolog
agent
respiratori
disord
isol
hong
kong
man
suffer
pneumonia
classifi
group
ii
coronaviru
woo
et
al
far
strain
detect
asia
europ
unit
state
australia
connect
respiratori
enter
tract
ill
esper
et
al
garbino
et
al
lau
et
al
sloot
et
al
vabret
et
al
coronaviru
diagnost
domin
nucleic
acid
technolog
nat
reconvalesc
lead
loss
viremia
nat
applic
coronaviru
screen
epidemiolog
survey
outsid
acut
pandem
eg
sar
serolog
far
rare
use
yet
develop
distinguish
pathogen
type
hcov
candid
antigen
immunoassay
detect
anticoronaviru
antibodi
structur
protein
special
interest
rna
bind
nucleocapsid
n
protein
exhibit
high
immunogen
abundantli
produc
infect
timani
et
al
sever
method
use
nucleocapsid
diagnost
antigen
design
special
emphasi
sar
n
guan
et
al
liang
et
al
tan
et
al
describ
establish
line
immunoassay
rapid
simultan
detect
antibodi
direct
known
hcov
sar
human
sera
base
recombin
viral
n
protein
clone
express
correspond
viral
gene
escherichia
coli
purifi
protein
subsequ
employ
line
immunoassay
test
suitabl
diagnost
antigen
hcov
atcc
atcc
obtain
american
type
cultur
collect
manassa
va
propag
cell
rna
isol
cell
cultur
supernat
use
sv
total
rna
isol
system
promega
mannheim
germani
kindli
provid
l
van
der
hoek
amsterdam
netherland
strain
caen
receiv
vabret
caen
franc
sarscovrna
strain
fra
prepar
sent
laboratori
eickmann
marburg
germani
revers
transcriptas
polymeras
chain
reaction
polymeras
chain
reaction
clone
coronavir
nucleocapsid
gene
cdna
synthes
mmlv
revers
transcriptas
promega
use
genespecif
revers
primer
deriv
full
genom
sequenc
see
tabl
genbank
access
number
subsequ
cdna
amplifi
util
hotstart
dna
polymeras
stratagen
heidelberg
germani
primer
pair
display
tabl
clone
site
overlap
start
codon
clone
site
downstream
stop
codon
introduc
indic
oligonucleotid
synthes
metabion
martinsri
germani
result
polymeras
chain
reaction
pcr
product
clone
express
vector
lindner
unpublish
deriv
novagen
schwalbach
germani
encod
ntermin
histidin
residu
purif
sequenc
ident
express
construct
confirm
dna
sequenc
geneart
regensburg
germani
e
coli
compet
cell
rp
stratagen
transform
construct
express
plasmid
transform
cell
grown
luriabertani
medium
supplement
ampicillin
chloramphenicol
vigor
shake
optic
densiti
nm
reach
approxim
nucleocapsid
protein
synthesi
induc
addit
final
concentr
mmoll
h
cell
harvest
centrifug
g
min
store
nucleocapsid
gene
sar
express
highli
solubl
protein
wherea
n
n
purifi
inclus
bodi
therefor
buffer
use
purif
n
n
supplement
moll
urea
respect
frozen
cell
g
wet
weight
thaw
suspend
load
buffer
contain
mmoll
sodium
phosphat
ph
mmoll
nacl
mmoll
imidazol
ml
per
gram
wet
weight
proteas
inhibitor
ad
disrupt
cell
mmoll
pefabloc
biomol
hamburg
germani
cell
lyse
passag
high
pressur
system
basicz
iul
instrument
germani
bar
avoid
dna
contamin
incub
crude
extract
uml
merck
darmstadt
germani
min
precipit
wv
protamin
sulfat
sigmaaldrich
steinheim
germani
lysat
clear
centrifug
g
min
solubl
histidinetag
nucleocapsid
protein
n
n
sar
n
present
supernat
purifi
affin
chromatographi
use
nisepharos
column
bed
volum
ml
ge
healthcar
munich
germani
bound
protein
elut
linear
gradient
imidazol
mmoll
load
buffer
nucleocapsidcontain
fraction
mmoll
imidazol
pool
dialyz
mmoll
sodium
phosphat
ph
mmoll
nacl
appli
spporo
ionexchang
column
bed
volum
ml
appli
biosystem
weiterstadt
germani
elut
conduct
load
buffer
mmoll
sodium
phosphat
ph
linear
gradient
mmoll
nacl
moll
nacl
nucleocapsid
fraction
mmoll
nacl
pool
load
prepar
superdex
gel
filtrat
column
bed
volum
ml
prep
grade
ge
healthcar
equilibr
load
buffer
mmoll
nacl
nucleocapsidcontain
fraction
pool
aliquot
store
insolubl
protein
n
n
purifi
describ
solubl
nucleocapsid
wherea
buffer
use
purif
n
n
supplement
moll
urea
respect
high
protein
puriti
confirm
analysi
coomassiestain
polyacrylamid
gel
fig
nucleocapsid
protein
concentr
determin
bicinchonin
acid
bca
method
sigmaaldrich
spectrophotometr
affin
chromatographi
gel
filtrat
perform
use
high
pharmacia
freiburg
germani
ionexchang
chromatographi
run
biocad
workstat
appli
biosystem
nucleocapsid
antigen
solut
n
n
sar
n
n
n
appropri
control
strong
posit
control
human
immunoglobulin
g
igg
weak
posit
control
human
igg
immobil
parallel
line
nitrocellulos
transfer
membran
protran
schleicher
schuell
dassel
germani
use
accutran
crossblot
system
schleicher
schuell
recombin
antigen
incub
membran
h
room
temperatur
soft
shake
nonspecif
bind
site
block
wv
tropix
bedford
supplement
vv
tween
h
final
membran
airdri
cut
strip
mm
store
acut
convalesc
phase
sera
patient
recent
infect
patient
recent
infect
obtain
serum
bank
respiratori
pathogen
research
unit
baylor
colleg
medicin
houston
tx
rb
couch
sampl
test
enzymelink
immunosorb
assay
elisa
well
microneutr
experi
convalesc
phase
sera
shown
high
antibodi
titer
sampl
convalesc
sar
patient
provid
chines
center
diseas
control
china
cdc
beij
pr
china
sera
collect
hospit
patient
sar
outbreak
inner
mongolia
pr
china
sarscov
infect
confirm
previous
elisa
western
blot
analysi
immunofluoresc
serum
sampl
deriv
healthi
donor
store
serum
bank
univers
regensburg
germani
screen
contamin
purif
step
use
polyclon
rabbit
anti
coli
antibodi
dako
hamburg
germani
detect
histag
recombin
protein
util
mous
penta
antibodi
dilut
qiagen
hilden
germani
rais
antisar
nucleocapsid
antibodi
inject
recombin
nucleocapsid
protein
rabbit
david
biotechnologi
regensburg
germani
western
blot
analysi
carri
rabbit
sar
n
antiserum
dilut
rabbit
n
antiserum
provid
l
van
der
hoek
amsterdam
netherland
use
dilut
primari
antibodi
sera
dilut
trisbuff
salin
tb
ph
secondari
detect
horseradish
peroxidas
hrp
conjug
polyclon
rabbit
antihuman
igg
dako
use
detect
antin
antibodi
human
sera
hrpconjug
polyclon
swine
antirabbit
ig
rabbit
antimous
ig
dako
use
detect
correspond
primari
antibodi
immunoassay
strip
incub
human
sera
dilut
tb
ph
total
incub
volum
ml
h
shake
wash
twice
min
tb
supplement
vv
tween
ttb
strip
incub
secondari
antibodi
solut
min
shake
reduc
background
matrix
effect
dilut
secondari
antibodi
buffer
contain
candor
bioscienc
germani
tb
wash
time
min
ttb
bound
antibodi
detect
colorimetr
addit
nicl
diaminobenzidin
solut
contain
h
min
step
perform
room
temperatur
nucleotid
sequenc
n
gene
strain
caen
deposit
genbank
sequenc
databas
access
number
genbank
access
number
list
tabl
clone
nucleotid
sequenc
n
n
n
sar
n
match
complet
publish
sequenc
wherea
nucleocapsid
gene
coronaviru
differ
slightli
alreadi
publish
sequenc
viral
rna
isol
nasal
aspir
sampl
infant
respiratori
infect
caen
franc
vabret
person
commun
use
revers
transcriptas
pcr
rtpcr
amplif
n
gene
newli
identifi
protein
sequenc
correspond
genbank
access
number
exhibit
amino
acid
ident
amino
acid
similar
n
protein
strain
access
number
genet
variabl
among
isol
studi
previous
sloot
et
al
woo
et
al
woo
et
al
classif
strain
caen
sequenc
pol
gene
necessari
nucleocapsid
gene
known
hcov
heterolog
express
e
coli
purifi
homogen
highli
purifi
recombin
antigen
shown
fig
lack
interf
protein
contamin
origin
express
host
demonstr
western
blot
purifi
nucleocapsid
fraction
bacteri
protein
detect
use
mous
anti
coli
antibodi
recombin
protein
could
identifi
purif
process
use
antibodi
recogn
ntermin
histidin
tag
data
shown
recombin
protein
immobil
horizont
line
membran
strip
optim
concentr
individu
determin
antigen
best
signaltonois
ratio
achiev
use
protein
concentr
data
shown
reliabl
test
system
improv
includ
strong
posit
human
igg
weak
posit
control
human
igg
strip
weak
posit
control
repres
cutoff
control
signal
intens
stronger
defin
weak
posit
control
consid
posit
perform
immunoassay
test
differ
sampl
pool
serum
pair
patient
suffer
infect
b
n
n
sera
gather
convalesc
sar
patient
n
randomli
select
specimen
healthi
donor
n
adult
children
unfortun
human
sera
collect
confirm
infect
avail
addit
rabbit
n
antiserum
rabbit
sar
n
antiserum
util
show
specif
reaction
respect
antigen
fig
antin
fig
experi
carri
least
triplic
first
serum
pair
acuteconvalesc
patient
suffer
infect
screen
regard
aspect
specif
sensit
reaction
immobil
antigen
comparison
signal
intens
fraction
bound
antibodi
relev
antigen
acut
convalesc
b
phase
sera
tabl
fig
sera
obtain
convalesc
patient
infect
react
respect
antigen
expect
strong
induct
humor
respons
observ
case
tabl
yet
amplifi
signal
intens
postinfect
sera
accompani
sturdi
reaction
antigen
except
overal
weak
signal
detect
tabl
tabl
howev
serum
respond
weakli
n
exhibit
distinct
reaction
n
antigen
observ
rais
possibl
collater
acut
infect
addit
defin
sera
patient
uniformli
show
presenc
basal
level
antibodi
stronger
antibodi
respons
case
sampl
necessarili
impli
nonspecif
crossreact
remark
none
test
coronaviru
posit
sera
react
sar
antigen
fig
tabl
analyz
sera
obtain
convalesc
sar
patient
sampl
show
strong
distinct
signal
sar
nucleocapsid
moreov
specimen
respond
n
n
n
n
repres
set
assay
strip
indic
varieti
obtain
antibodi
reaction
display
fig
tabl
reaction
clinic
defin
sera
hcov
nucleocapsid
sera
taken
acut
phase
hcov
infect
antibodi
could
detect
wherea
sampl
collect
convalesc
strongli
react
correspond
antigen
coreact
nucleocapsid
nucleocapsid
might
due
crossreact
twentyf
sera
randomli
select
healthi
blood
donor
test
investig
natur
coronaviru
preval
appli
sampl
line
immunoassay
found
evid
singl
doubl
multipl
coronaviru
infect
variou
combin
fig
also
abl
identifi
blood
sampl
show
seroconvers
deriv
children
fig
summari
sera
collect
healthi
donor
react
hcov
nucleocapsid
follow
expect
respons
sar
n
detect
fig
sar
epidem
led
boost
coronaviru
research
two
far
unknown
virus
sinc
identifi
detect
hcov
futur
like
major
techniqu
diagnos
hcov
infect
today
rtpcr
wherea
serolog
assay
distinguish
type
hcov
knowledg
almost
complet
miss
yet
epidemiolog
studi
regard
coronaviru
preval
great
interest
howev
techniqu
nucleic
acid
diagnost
suitabl
coronavir
rna
detect
acut
phase
infect
shortli
thereaft
addit
clinic
symptom
mild
miss
altogeth
serolog
open
possibl
identifi
silent
convert
case
sar
repres
highli
valuabl
inform
actual
viru
distribut
among
popul
base
previou
report
timani
et
al
zhu
et
al
protein
sequenc
comparison
reveal
rel
low
sequenc
ident
similar
tabl
consid
nucleocapsid
protein
appropri
antigen
marker
retrospect
diagnosi
coronaviru
infect
human
highest
amino
acid
sequenc
ident
present
nucleocapsid
ident
similar
n
protein
sequenc
coronavirus
consid
antigen
immunoassay
exhibit
much
lower
amino
acid
ident
compar
ident
similar
tabl
therefor
establish
line
immunoassay
use
recombin
n
protein
antigen
specif
detect
coronavirusdirect
antibodi
human
sera
valid
newli
develop
test
carri
assay
welldefin
sera
patient
suffer
variou
coronavir
infect
consist
avail
human
sera
sampl
convalesc
patient
test
posit
hcov
sarscov
microneutr
experi
western
blot
elisa
react
respect
antigen
expect
indic
excel
sensit
line
immunoassay
although
antigen
crossreact
sar
nucleocapsid
describ
earlier
sun
meng
woo
et
al
yip
et
al
could
detect
serolog
crossreact
sar
n
even
case
donor
strongli
fig
arbitrarili
select
sera
healthi
donor
appli
line
immunoassay
singl
doubl
multipl
anticoronavir
immun
respons
variou
combin
could
verifi
shown
addit
blood
sampl
without
seroconvers
identifi
serum
rabbit
immun
truncat
nucleocapsid
use
respond
nucleocapsid
fig
accordingli
sera
obtain
convalesc
sar
patient
react
sar
antigen
moreov
antibodi
bind
reaction
sar
n
consist
strong
demonstr
fig
identifi
sampl
show
singl
distinct
band
prove
presenc
antisarscov
antibodi
five
specimen
react
addit
hcov
antigen
eg
fig
deriv
preexist
antibodi
anterior
hcov
infect
base
find
conclud
evid
nonspecif
bind
sarsspecif
antibodi
antigen
hcov
convalesc
sar
sera
thu
sar
n
protein
provid
power
tool
differenti
sar
infect
infect
hcov
serolog
studi
howev
crossreact
among
hcov
might
occur
n
protein
group
hcov
display
highest
amino
acid
ident
among
coronavirus
tabl
nonspecif
bind
antibodi
direct
n
n
possibl
observ
fig
tabl
donor
serum
sampl
test
infect
sampl
character
primari
detect
howev
doubl
infect
seem
unlik
simultan
detect
antibodi
occur
serum
pair
nonetheless
also
test
sera
compris
igg
recogn
n
without
bind
n
fig
contradict
gener
crossreact
nonspecif
crossreact
group
hcov
antigen
appear
rather
unlik
amino
acid
ident
nucleocapsid
rel
low
tabl
nevertheless
singl
serum
sampl
antibodi
respons
seem
coinduc
tabl
fig
defin
sera
sampl
patient
consist
indic
antibodi
bind
signal
n
sera
initi
character
presenc
viral
agent
actual
discov
sampl
time
thu
proof
antibodi
sera
necessarili
evid
crossreact
coinfect
previou
contact
earlier
live
patient
result
basal
antibodi
level
exclud
furthermor
posit
reaction
n
n
sampl
fig
tabl
could
due
true
infect
antibodi
specif
hcov
identifi
adult
throughout
world
modrow
et
al
although
immunolog
data
concern
seropreval
antibodi
avail
hruskova
et
al
mourez
et
al
inform
humor
respons
concern
recent
discov
rather
scarc
despit
widespread
associ
respiratori
tract
infect
global
sar
epidem
control
highli
success
public
health
effort
report
case
sinc
april
thu
appear
sarscov
current
circul
human
howev
studi
actual
distribut
sarscov
lack
survey
screen
healthi
donor
antibodi
specif
sarscov
rare
yu
et
al
contact
lead
seroconvers
may
result
asymptomat
subclin
manifest
che
et
al
wildersmith
et
al
therefor
recogn
sar
infect
henc
serolog
remain
import
tool
sar
diagnosi
decid
test
arbitrarili
select
sera
assum
sampl
collect
adult
would
exhibit
posit
igg
reaction
least
possibl
sever
coronaviru
nucleocapsid
sustain
coronaviru
infect
becom
like
increas
age
consist
assumpt
found
sera
recogn
antigen
except
sar
well
sampl
show
evid
infect
singl
type
viru
furthermor
identifi
hcovneg
sera
children
adult
although
test
children
like
never
contact
coronavirus
seroneg
adult
might
coronaviru
infect
earlier
life
becam
nondetect
antinucleocapsid
igg
titer
decreas
time
conclus
consid
line
immunoassay
approach
highli
favor
largescal
epidemiolog
studi
coronavirus
assay
system
allow
rapid
easi
detect
antibodi
known
hcov
singl
experi
antigenco
strip
requir
low
serum
volum
replac
secondari
antihuman
igg
antihuman
igm
immunoassay
could
easili
adjust
screen
human
igm
might
flank
rtpcrbase
diagnosi
acut
hcov
infect
clinic
set
context
would
advis
test
sequenti
acut
convalesc
serum
sampl
track
seroconvers
defin
immunoassay
role
diagnosi
acut
infect
assay
setup
test
strip
product
straightforward
costeffect
n
protein
appropri
antigen
extrem
immunogen
provid
sensit
reliabl
tool
antibodi
detect
yet
beyond
acut
infect
data
also
indic
crossreact
epitop
among
hcov
within
group
group
ii
might
involv
igg
respons
hcov
nucleocapsid
addit
line
immunoassay
may
detect
remot
infect
experienc
past
gain
even
better
specif
exclud
possibl
falseposit
result
would
benefici
extend
antigen
portfolio
strip
therefor
futur
experi
aim
addit
studi
focus
potenti
crossreact
finetun
assay
inclus
antigen
specif
immunoreact
peptid
addit
fulllength
n
protein
